| [1] |
DRON JS, WANG J, MCINTYRE AD, et al. The polygenic nature of mild-to-moderate hypertriglyceridemia[J]. J Clin Lipidol, 2020, 14( 1): 28- 34. DOI: 10.1016/j.jacl.2020.01.003. |
| [2] |
MEDEROS MA, REBER HA, GIRGIS MD. Acute pancreatitis: A review[J]. JAMA, 2021, 325( 4): 382- 390. DOI: 10.1001/jama.2020.20317. |
| [3] |
FORTSON MR, FREEDMAN SN, WEBSTER PD 3rd. Clinical assessment of hyperlipidemic pancreatitis[J]. Am J Gastroenterol, 1995, 90( 12): 2134- 2139.
|
| [4] |
CARR RA, REJOWSKI BJ, COTE GA, et al. Systematic review of hypertriglyceridemia-induced acute pancreatitis: A more virulent etiology?[J]. Pancreatology, 2016, 16( 4): 469- 476. DOI: 10.1016/j.pan.2016.02.011. |
| [5] |
ZHENG Y, ZHOU Z, LI H, et al. A multicenter study on etiology of acute pancreatitis in Beijing during 5 years[J]. Pancreas, 2015, 44( 3): 409- 414. DOI: 10.1097/MPA.0000000000000273. |
| [6] |
JIN M, BAI X, CHEN X, et al. A 16-year trend of etiology in acute pancreatitis: The increasing proportion of hypertriglyceridemia-associated acute pancreatitis and its adverse effect on prognosis[J]. J Clin Lipidol, 2019, 13( 6): 947- 953. DOI: 10.1016/j.jacl.2019.09.005. |
| [7] |
LI XY, KE L, DONG J, et al. Significantly different clinical features between hypertriglyceridemia and biliary acute pancreatitis: A retrospective study of 730 patients from a tertiary center[J]. BMC Gastroenterol, 2018, 18( 1): 89. DOI: 10.1186/s12876-018-0821-z. |
| [8] |
WU YQ, ZHAO JC. Predictive value of Ranson score in the classification of moderate to severe hyperlipidemia acute pancreatitis[J]. J Clin Exp Med, 2022, 21( 2): 222- 225. DOI: 10.3969/j.issn.1671-4695.2022.02.029. |
| [9] |
SU W, GUO F. Triglyceride-controlling during acute phase of hypertriglyceridemia induced pancreatitis[J]. Chin J Dig Surg, 2023, 22( 1): 89- 93. DOI: 10.3760/cma.j.cn115610-20221220-00755. |
| [10] |
FAN JY, YAO Y, FENG L, et al. Relationship of serum creatinine, PLT and HCT with the severity and prognosis of hyperlipidemic acute pancreatitis[J]. J Clin Exp Med, 2023, 22( 10): 1049- 1052. DOI: 10.3969/j.issn.1671-4695.2023.10.011. |
| [11] |
LI XY, YANG Q, SHI XL, et al. Compound but non-linked heterozygous p.W14X and p.L279 V LPL gene mutations in a Chinese patient with long-term severe hypertriglyceridemia and recurrent acute pancreatitis[J]. Lipids Health Dis, 2018, 17( 1): 144. DOI: 10.1186/s12944-018-0789-2. |
| [12] |
BASEL-VANAGAITE L, ZEVIT N, ZAHAV AH, et al. Transient infantile hypertriglyceridemia, fatty liver, and hepatic fibrosis caused by mutated GPD1, encoding glycerol-3-phosphate dehydrogenase 1[J]. Am J Hum Genet, 2012, 90( 1): 49- 60. DOI: 10.1016/j.ajhg.2011.11.028. |
| [13] |
OU XJ, JI CN, HAN XQ, et al. Crystal structures of human glycerol 3-phosphate dehydrogenase 1(GPD1)[J]. J Mol Biol, 2006, 357( 3): 858- 869. DOI: 10.1016/j.jmb.2005.12.074. |
| [14] |
POLCHAR L, VALLABHANENI P. Case of GPD1 deficiency causing hypertriglyceridaemia and non-alcoholic steatohepatitis[J]. BMJ Case Rep, 2022, 15( 4): e246369. DOI: 10.1136/bcr-2021-246369. |
| [15] |
LI JQ, XIE XB, FENG JY, et al. A novel homozygous mutation in the glycerol-3-phosphate dehydrogenase 1 gene in a Chinese patient with transient infantile hypertriglyceridemia: A case report[J]. BMC Gastroenterol, 2018, 18( 1): 96. DOI: 10.1186/s12876-018-0827-6. |
| [16] |
DIONISI-VICI C, SHTEYER E, NICETA M, et al. Expanding the molecular diversity and phenotypic spectrum of glycerol 3-phosphate dehydrogenase 1 deficiency[J]. J Inherit Metab Dis, 2016, 39( 5): 689- 695. DOI: 10.1007/s10545-016-9956-7. |
| [17] |
JOSHI M, EAGAN J, DESAI NK, et al. A compound heterozygous mutation in GPD1 causes hepatomegaly, steatohepatitis, and hypertriglyceridemia[J]. Eur J Hum Genet, 2014, 22( 10): 1229- 1232. DOI: 10.1038/ejhg.2014.8. |
| [18] |
LI N, CHANG GY, XU YF, et al. Biallelic mutations in GPD1 gene in a Chinese boy mainly presented with obesity, insulin resistance, fatty liver, and short stature[J]. Am J Med Genet A, 2017, 173( 12): 3189- 3194. DOI: 10.1002/ajmg.a.38473. |
| [19] |
LIN HH, FANG YH, HAN L, et al. Case report: Identification of a novel homozygous mutation in GPD1 gene of a Chinese child with transient infantile hypertriglyceridemia[J]. Front Genet, 2021, 12: 726116. DOI: 10.3389/fgene.2021.726116. |
| [20] |
MATARAZZO L, RAGNONI V, MALAVENTURA C, et al. Successful fenofibrate therapy for severe and persistent hypertriglyceridemia in a boy with cirrhosis and glycerol-3-phosphate dehydrogenase 1 deficiency[J]. JIMD Rep, 2020, 54( 1): 25- 31. DOI: 10.1002/jmd2.12125. |
| [21] |
WANG J, SUN F, XU PF, et al. Transient infantile hypertriglyceridemia with jaundice: A case report[J]. Medicine, 2021, 100( 17): e25697. DOI: 10.1097/MD.0000000000025697. |
| [22] |
KUMAR P, SHARMA S. Transient infantile hypertriglyceridemia and hepatic steatosis in an infant with GPD1 mutation[J]. Indian J Pediatr, 2021, 88( 5): 495- 496. DOI: 10.1007/s12098-021-03663-2. |
| [23] |
TESAROVA M, STRANECKY V, KONECNA P, et al. GPD1 deficiency-underdiagnosed cause of liver disease[J]. Indian J Pediatr, 2021, 88( 1): 80- 81. DOI: 10.1007/s12098-020-03385-x. |
| [24] |
XIE XB, LI MP, WANG JS. Transient infantile hypertriglyceridemia caused by GPD1 deficiency: report of two cases and literature review[J]. Chin J Pediatr, 2020, 58( 11): 923- 927. DOI: 10.3760/cma.j.cn112140-20200411-00375. |
| [25] |
MA PF, LI WQ, CHEN L, et al. A case of transient infantile hypertriglyceridemia caused by mutations in the glycerol-3-phosphate dehydrogenase 1 gene[J]. Chin J Hepatol, 2021, 29( 10): 1014- 1016. DOI: 10.3760/cma.j.cn501113-20210122-00040. |
DownLoad:
